Skip to main content

Table 2 Characteristics of Combination therapy

From: The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study

Characteristic Total n (%)
Capecitabine 1 (6.3)
S-1 8 (50.0)
Oxaliplatin 1 (6.3)
Irinotecan 2 (12.2)
PD-1 inhibitor 4 (25.0)
  1. PD-1 Programmed cell death-1